Clinic
Riverside Treatment Services LLC
Riverside Treatment Services LLC was paid $56.30M by Medicaid between Jan 2018 and Dec 2024, across 12 billing codes. Its largest line is H0020, Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) — 51% of everything it billed.
33Billing provider infoRIVERSIDE TREATMENT SERVICES LLC
ROSEDALE, MD 21237
ROSEDALE, MD 21237
33aNPI1801258736assigned 03/21/2016
33bProvider typeMethadone Clinic
28Total paid$56.30M
24GClaims1,169,123
24DCodes billed12
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Methadone Clinic providers in Maryland
Rank by total paid#1 of 68
Median peer was paid$5.93M
This provider vs. median9.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 183,944 | $6.86M | |
| 2019 | 198,432 | $8.08M | |
| 2020 | 174,039 | $7.87M | |
| 2021 | 170,458 | $8.10M | |
| 2022 | 158,933 | $8.55M | |
| 2023 | 149,724 | $8.52M | |
| 2024incomplete | 133,593 | $8.31M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 51% | 373,509 | 89,817 | $28.55M |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 17% | 108,279 | 91,886 | $9.38M |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 15% | 412,631 | 15,392 | $8.30M |
| H0047 | Alcohol and/or other drug abuse services, not otherwise specified | 8.2% | 68,763 | 17,015 | $4.62M |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | 4.1% | 176,301 | 7,446 | $2.29M |
| H0001 | Alcohol and/or drug assessment | 3.3% | 10,448 | 10,369 | $1.84M |
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | 1.5% | 3,476 | 3,452 | $847K |
| J0573 | Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine | <1% | 9,900 | 340 | $214K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 1,869 | 1,547 | $140K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,130 | 2,728 | $68K |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | <1% | 580 | 260 | $38K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | <1% | 237 | 153 | $3K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWATSON, CHARLES (DIRECTOR)